Loading organizations...
Key people at IMPAC Medical Systems.
IMPAC Medical Systems, based in Mountain View, California, developed integrated oncology management software, including EMR for radiation and medical oncology, digital image management, practice management, and cancer registry tools, to support cancer patient care teams. By 2005, their software was utilized by nearly 80% of U.S. cancer clinics, serving almost 1,700 clients across 52 countries, with systems in over 1,300 North American oncology centers, 1,100 cancer registries, and 400 pathology labs. Founded in 1990 by David Auerbach, Jay Hoey, and Joe Jachinowski, IMPAC received early backing from Investor Summit Partners. The company, with over 110 employees by 2002, went public on Nasdaq in 2002. It was subsequently acquired by Elekta AB in 2005 for $190 million.
IMPAC Medical Systems, Inc. was a pioneering oncology software company that developed integrated information management systems for radiation and medical oncology practices, including electronic charting, image management, practice management, and cancer registry tools.[1][2][3] Its flagship offerings, such as MOSAIQ, streamlined clinical workflows, patient scheduling, treatment planning, and data exchange with external systems like labs and registries, serving nearly 1,700 clients worldwide across 52 countries, including leading US cancer centers and private practices.[1][3] The company addressed critical needs in oncology care by improving efficiency, data tracking for outcomes and quality of life, and maintaining the National Oncology Data Base (NODB) with over 2 million cases for research.[1]
Acquired by Elekta AB in 2005, IMPAC transitioned into Elekta Impac Software, enhancing Elekta's portfolio in oncology IT and radiation therapy solutions.[2][3][6] This integration supported robust growth, with Elekta reporting strong profitability and revenue expectations post-acquisition.[2]
IMPAC Medical Systems was founded around 1990 in a Silicon Valley garage by three entrepreneurs—David Auerbach, Jay (likely Jay Gonyear), and others—who recognized the need for independent software to manage increasingly computer-intensive radiation therapy machines and integrate data from diverse clinic applications.[1][6] The first system shipped in Q1 1991, focusing on oncology-specific tools amid manual treatment setups at the time.[1][6] Early emphasis was on interoperability with external systems, vital for oncology departments within larger healthcare providers.[1]
The company gained traction quickly, listing on Nasdaq in 2002 with over 110 employees and 80% of US cancer clinics as customers.[6] Backed by investors like Summit Partners, IMPAC provided clinical and administrative systems for cancer specialists.[5] The pivotal 2005 acquisition by Elekta for strategic expansion into oncology IT marked its evolution from startup to part of a global medtech leader.[2][6]
Post-acquisition, these strengths fueled Elekta's advancements in Big Data, SaaS, cloud, and imaging handling for precise treatments.[6]
IMPAC rode the early 1990s wave of healthcare IT digitization, particularly in oncology, where radiation therapy shifted from manual to computer-driven processes amid rising cancer prevalence and complex treatments.[1][6] Its timing capitalized on needs for integrated data management as clinics adopted imaging and multi-vendor equipment, filling gaps before widespread EHR adoption.[1][6] Market forces like regulatory demands for cancer registries and outcomes reporting favored IMPAC's tools.[1]
By pioneering oncology-specific software, IMPAC influenced the ecosystem, setting standards for workflow efficiency and data interoperability that Elekta expanded globally, accelerating oncology IT innovation and research through assets like NODB.[1][2][6]
IMPAC's legacy as an oncology software trailblazer endures within Elekta, where its systems continue powering cancer care amid digital health evolution.[3][6] Next steps likely involve deeper AI integration, cloud-native upgrades, and real-time imaging analytics to handle escalating data from adaptive therapies.[6] Trends like precision oncology, Big Data for personalized treatments, and SaaS scalability will shape its trajectory, potentially amplifying Elekta's market dominance as global cancer cases rise. This positions IMPAC's foundational innovations to drive ongoing efficiencies, tying back to its garage origins in solving real-world oncology bottlenecks.
Key people at IMPAC Medical Systems.
